Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Endocrinol Metab. 2011 Oct;96(10):3007-19. doi: 10.1210/jc.2011-1137. Epub 2011 Aug 3.

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.

Author information

  • 1Department of Epidemiology, New England Research Institutes, Inc, Watertown, Massachusetts 02472, USA. aaraujo@neriscience.com

Abstract

CONTEXT:

Low testosterone levels have been associated with outcomes that reduce survival in men.

OBJECTIVE:

Our objective was to perform a systematic review and meta-analysis of published studies to evaluate the association between endogenous testosterone and mortality.

DATA SOURCES:

Data sources included MEDLINE (1966 to December 2010), EMBASE (1988 to December 2010), and reference lists.

STUDY SELECTION:

Eligible studies were published English-language observational studies of men that reported the association between endogenous testosterone and all-cause or cardiovascular disease (CVD) mortality. A two-stage process was used for study selection. 1) Working independently and in duplicate, reviewers screened a subset (10%) of abstracts. Results indicated 96% agreement, and thereafter, abstract screening was conducted in singlicate. 2) All full-text publications were reviewed independently and in duplicate for eligibility.

DATA EXTRACTION:

Reviewers working independently and in duplicate determined methodological quality of studies and extracted descriptive, quality, and outcome data.

DATA SYNTHESIS:

Of 820 studies identified, 21 were included in the systematic review, and 12 were eligible for meta-analysis [n = 11 studies of all-cause mortality (16,184 subjects); n = 7 studies of CVD mortality (11,831 subjects)]. Subject mean age and testosterone level were 61 yr and 487 ng/dl, respectively, and mean follow-up time was 9.7 yr. Between-study heterogeneity was observed among studies of all-cause (P < .001) and CVD mortality (P = 0.06), limiting the ability to provide valid summary estimates. Heterogeneity in all-cause mortality (higher relative risks) was observed in studies that included older subjects (P = 0.020), reported lower testosterone levels (P = 0.018), followed subjects for a shorter time period (P = 0.010), and sampled blood throughout the day (P = 0.030).

CONCLUSION:

Low endogenous testosterone levels are associated with increased risk of all-cause and CVD death in community-based studies of men, but considerable between-study heterogeneity, which was related to study and subject characteristics, suggests that effects are driven by differences between cohorts (e.g. in underlying health status).

PMID:
21816776
[PubMed - indexed for MEDLINE]
PMCID:
PMC3200249
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk